Clinical Trial Publications

CHRYSALIS

• Park K, Haura EB, Leighl NB, et al. Amivantamab in EGFR exon 20 insertion-mutated non-small cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study. J Clin Oncol. 2021. 39(30):3391-3402.

• Park K, Haura EB, Leighl NB, et al. Supplementary Appendix for: Amivantamab in EGFR exon 20 insertion-mutated non-small cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study. J Clin Oncol. 2021. 2021.39(30):3391-3402